Medirom Healthcare Technologies (MRM) Debt to Equity (2019 - 2025)

Historic Debt to Equity for Medirom Healthcare Technologies (MRM) over the last 7 years, with Q2 2025 value amounting to $5.55.

  • Medirom Healthcare Technologies' Debt to Equity rose 28322.83% to $5.55 in Q2 2025 from the same period last year, while for Jun 2025 it was $5.55, marking a year-over-year increase of 28322.83%. This contributed to the annual value of $1.48 for FY2024, which is 7281.54% down from last year.
  • According to the latest figures from Q2 2025, Medirom Healthcare Technologies' Debt to Equity is $5.55, which was up 28322.83% from $1.48 recorded in Q4 2024.
  • Medirom Healthcare Technologies' 5-year Debt to Equity high stood at $5.55 for Q2 2025, and its period low was -$21.03 during Q4 2022.
  • Over the past 5 years, Medirom Healthcare Technologies' median Debt to Equity value was -$1.79 (recorded in 2022), while the average stood at -$1.88.
  • Its Debt to Equity has fluctuated over the past 5 years, first tumbled by 38217.7% in 2022, then surged by 28322.83% in 2025.
  • Medirom Healthcare Technologies' Debt to Equity (Quarter) stood at -$4.36 in 2021, then tumbled by 382.18% to -$21.03 in 2022, then surged by 125.95% to $5.46 in 2023, then tumbled by 72.82% to $1.48 in 2024, then surged by 274.21% to $5.55 in 2025.
  • Its Debt to Equity stands at $5.55 for Q2 2025, versus $1.48 for Q4 2024 and -$3.03 for Q2 2024.